SELECT Trial and Implications for Population Health

Sdílet
Vložit
  • čas přidán 10. 11. 2023
  • Chiadi Ndumele MD, MHS, Phd and Tiffany Powell-Wiley, MD, MPH discuss the results of the SELECT trial and the potential impact of the semaglutide as a treatment for obesity.
    Follow us at @AHAScience and see full coverage of #AHA23 at professional.heart.org/en/mee...
  • Věda a technologie

Komentáře • 1

  • @b.a.d.2086
    @b.a.d.2086 Před 6 měsíci

    HFpEF is probably most common in elderly women living on very modest means. Semaglutide costs more than many persons entire Social Security income.